Outlast Bioscience develops targeted, non-hormonal solutions that restore a healthy vaginal microbiome — guided by science, designed for every stage of a woman's life.
The vagina is home to a living ecosystem — a community of microorganisms that protects, adapts, and responds throughout a woman's life. When it thrives, she thrives.
A healthy vaginal microbiome is dominated by protective Lactobacillus species — above all L. crispatus. They produce lactic acid, maintain a low pH, and form a natural barrier against unwanted microbes.
Hormonal shifts, antibiotics, intimate products, and life stages like menopause can tip the ecosystem into dysbiosis — an imbalance linked to discomfort, recurrent infections, and reduced quality of life.
Antibiotics clear symptoms but also clear the protectors — imbalance frequently returns. Hormonal therapies aren't right for every woman. Most intimate products are, at best, passive: they avoid harm but restore nothing.
Advances in microbiome science make it possible to selectively nourish the protective species while discouraging the disruptive ones — actively guiding the ecosystem back to balance, without hormones or antibiotics.
Solutions that rebuild the protective flora — rather than wiping it out — could break the cycle of recurrent infections, reduce reliance on repeated antibiotics, and give women options that work with their biology.
A resilient vaginal ecosystem means more than symptom relief: everyday comfort and confidence, support for fertility and healthy pregnancies, and gentler transitions through menopause — lifelong health, built on a woman's own microbiome.
The question is no longer whether the vaginal microbiome matters — it's how to restore it, gently and precisely.
We develop targeted, non-hormonal solutions that restore a healthy vaginal ecosystem. One scientific foundation — selective microbiome modulation — powers everything we make.
Support the protective microbiome in everyday intimate life — beginning with moments where conventional products disrupt the ecosystem most.
Help the ecosystem adapt through hormonal transitions — including menopause, when over half of women experience vaginal discomfort with few microbiome-aware options.
Guide recovery from dysbiosis — a non-antibiotic path for conditions like recurrent bacterial vaginosis, where today's standard of care too often fails to last.
Three promises. One platform. A portfolio of category-specific products.
From intimate wellness to clinically validated vaginal microbiome solutions — each product carries the same active formulation philosophy further along the evidence pathway.
Clinical evidence programs run in parallel with market availability — wellness products today, medically claimed solutions tomorrow.
Every category we enter has incumbents — none of them work with the microbiome itself.
Where premium lubricants merely avoid harm, ours actively supports the protective microbiome during intimacy.
Hyaluronic-acid gels relieve dryness for a moment. We address the microbial shift underneath it — without hormones.
Standard BV treatment sees half of women relapse within a year. Our non-antibiotic approach rebuilds the protective flora itself.
Intimacy is a two-person ecosystem. We're defining the first couples' category built on microbiome science.
We envision a future where every woman can maintain lifelong vaginal health by restoring — not disrupting — her microbiome, without hormones or antibiotics.
From first intimacy to menopause and beyond: health that lasts, built on the ecosystem a woman already carries.
Microbiome scientists, clinicians, and consumer-health operators — united by one mission. Hover a card for the full story.
President of PhenoBiome — the microbiome biotech whose functional-profiling platform powers Outlast's formulations. 8× serial entrepreneur across consumer health and biotech. Leads commercial strategy and partnerships.
Associate Professor at Karolinska Institutet; expert in women's health and microbiome science. Former biotech CEO with 25+ years across pharma R&D and commercialization. Author of Vulva — and the artist behind the watercolors on this page.
Founder, The Microbiome Mavericks and SwipeBiome. Former Director, Microbiome Excellence Center @ Beiersdorf; former Director of R&D, S-Biomedic (acquired by Beiersdorf). European Commission expert advisor. PhD INRAe; ex-Max Planck.
Obstetrician and gynaecologist. Founder of Quanna. Clinical lead on product reformulation, regulatory strategy, and clinical study design. Brings direct OB-GYN perspective to every product decision.
Co-founder, Back to Balance Test. Wellness Specialist at Libi & Daughters; Medical Specialist at Dajani Pharmacies. Operations, manufacturing, retail execution, and day-to-day delivery.
The watercolor artworks flowing through this page are original works by our co-founder Ina Schuppe Koistinen — science and art, from the same hand.
Partnerships, science, press, or just curiosity — we'd love to hear from you.
info@outlast.com